Updated Information from CDC on COVID-19 Vaccine for Individuals who Received Primary Vaccination Not Approved/Authorized in the US

The CDC recently updated the Emergency Use Instructions (EUI) and clinical guidance for persons who received primary vaccination with vaccines not approved/authorized in the U.S. The updated EUI and clinical guidance state that individuals who received an incomplete series of a vaccine listed for emergency use by the WHO but not authorized nor approved by the FDA no longer need to restart the primary COVID-19 vaccine series in the U.S. Instead, these individuals may now receive a single dose of Pfizer-BioNTech COVID-19 vaccine at least 28 days after receipt of their most recent dose, after which they will be considered fully vaccinated.

Attached are updated documents: